D-1545-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- October 5, 2022
- Initiation Date
- September 15, 2022
- Termination Date
- January 10, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 641,160 ampules
Product Description
Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide in the USA and Puerto Rico
Code Information
Lot #s: GA20080, GA20081, GA20094, Exp. 01/2024